RYR2 and heart failure: This study demonstrates that inhibition of Ca2+ leak via RyR2 pauses the transition to heart failure by reducing cardiac fibrosis, increasing repolarization lability, and decreasing QT heterogeneity, improving chronotropic competency, ultimately improving LV contractility, and mitigating lethal VT/VF.